Supplementary Figure 4 from PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN
openalex（2023）
摘要
Immune cell density by PD-L1 expression
查看译文
关键词
metastatic renal cell carcinoma,renal cell carcinoma,cabozantinib,sunitinib,randomized clinical trials meteor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要